Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Skin Neoplasms 2Neoplasms 2Melanoma 2Neoplasm Metastasis 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 280Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × Allovectin-7 × Clear all
NCT00003646 2011-07-07

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

Vical

Phase 2 Completed
78 enrolled
Dermatologic

Melanoma, Neoplasms, Skin Neoplasms

NCT00044356 2011-07-07

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Vical

Phase 2 Completed
133 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis, Neoplasms, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡